Continuous Administration of Basic Fibroblast Growth Factor (FGF-2) Accelerates Bone Induction on Rat Calvaria— An Application of a New Drug Delivery System

Abstract

Some studies have shown that locally applied basic fibroblast growth factor (FGF-2) enhances bone regeneration at a fracture site, while others have not been in agreement. We developed a new continuous FGF-2 delivery system designed to accelerate cytokine-induced new bone formation. A subperiosteal pocket was surgically formed in 36 eight-week-old male Wistar rats. The rats were administered 0, 1, 10, or 100 ng of FGF-2 contained in a collagen minipellet, mixed with allogeneic demineralized bone matrix in a dome-shaped Millipore® filter and then placed into the pocket. New bone formation in the dome was evaluated at 2, 4, and 8 wks after placement. Soft x-ray radiographs disclosed an apparently larger radiopaque region in the 1-ng group at 4 wks compared with those in the other groups. Morphometrical analysis revealed that the new bone area in the 1-g group was significantly larger than that in the 0-g group (p < 0.01). In the 100-ng FGF-2 group, new bone formation seemed suppressed. We concluded that continuous slow administration of a small amount of FGF-2 accelerates bone-derived osteogenic cytokine-induced new bone formation.

Keywords

basic fibroblast growth factor new drug delivery system bone induction.

References

Aspenberg P. , Thorngren KG , Lohmander LS (1991). Dose-dependent stimulation of bone induction by basic fibroblast growth factor in rats. Acta Orthop Scand 62 :481-484.

Baylink DJ , Finkelman RD , Mohan S. (1993). Growth factors to stimulate bone formation. J Bone Miner Res 8(Suppl 2) :S565-S572.

Bland YS , Critchlow MA , Ashhurst DE (1995). Exogenous fibroblast growth factors-1 and -2 do not accelerate fracture healing in the rabbit. Acta Orthop Scand 66:543-548.

Bolander ME (1992). Regulation of fracture repair by growth factors . Proc Soc Exp Biol Med 200:165-170.

Fujioka K. , Takada Y. , Sato S. , Miyata T. (1995a). Long-acting delivery system of interferon: IFN minipellet. J Control Release 33:317-323.

Fujioka K. , Takada Y. , Sato S. , Miyata T. (1995b). Novel delivery system for proteins using collagen as a carrier material: the minipellet. J Control Release 33:307-315.

Globus RK , Patterson Buckendahl P. , Gospodarowicz D. (1988). Regulation of bovine bone cell proliferation by fibroblast growth factor and transforming growth factor beta. Endocrinology 123:98-105.

Gospodarowicz D. (1990). Fibroblast growth factor. Chemical structure and biologic function. Clin Orthop 257:231-248.

Gospodarowicz D. , Moran JS (1974). Stimulation of division of sparse and confluent 3T3 cell populations by a fibroblast growth factor, dexamethasone, and insulin . Proc Natl Acad Sci USA 71:4584-4588.

10.

Hiraki Y. , Inoue H. , Shigeno C. , Sanma Y. , Bentz H. , Rosen DM , et al. (1991). Bone morphogenetic proteins (BMP-2 and BMP-3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3-El cells in vitro. J Bone Miner Res 6:1373-1385.

11.

Hirasawa T. , Sano A. , Fujioka K. , Inoue K. , Miyata K. , Nakano M. , et al. (1997). Biodegradability of minipellet, a new drug formulation using atelocollagen as a drug carrier material, in the rhesus monkey. Biomed Res 18:149-159.

12.

Hollinger J. (1993). Factors for osseous repair and delivery. Part I. J Craniofac Surg 4:102-108.

13.

Kato Y. , Iwamoto M. (1990). Fibroblast growth factor is an inhibitor of chondrocyte terminal differentiation. J Biol Chem 265:5903-5909.

14.

Kawaguchi H. , Kurokawa T. , Hanada K. , Hiyama Y. , Tamura M. , Ogata E. , et al. (1994). Stimulation of fracture repair by recombinant human basic fibroblast growth factor in normal and streptozotocin-diabetic rats. Endocrinology 135:774-781.

15.

Mazue G. , Bertolero F. , Garofano L. , Brughera M. , Carminati P. (1992). Experience with the preclinical assessment of basic fibroblast growth factor (bFGF). Toxicol Lett 64-65(Spec No):329-338.

16.

Mazue G. , Newman AJ , Scampini G. , Della Torre P. , Hard GC , Iatropoulos MJ , et al. (1993). The histopathology of kidney changes in rats and monkeys following intravenous administration of massive doses of FCE 26184, human basic fibroblast growth factor. Toxicol Pathol 21:490-501.

17.

Mohan S. , Baylink DJ (1991). Bone growth factors. Clin Orthop 263:30-48.

18.

Neigel JM , Ruzicka PO (1996). Use of demineralized bone implants in orbital and craniofacial reconstruction and a review of the literature. Ophthalmol Plast Reconstr Surg 12:108-120.

19.

Reddi AH , Huggins C. (1972). Biochemical sequences in the transformation of normal fibroblasts in adolescent rats. Proc Natl Acad Sci 69:1601-1605.

20.

Rudkin GH , Miller TA (1996). Growth factors in surgery. Plast Reconstr Surg 97:469-476.

21.

Wang JS ( 1996). Basic fibroblast growth factor for stimulation of bone formation in osteoinductive or conductive implants. Acta Orthop Scand 269(Suppl):1-33.

22.

Wang JS , Aspenberg P. (1994). Basic fibroblast growth factor increases allograft incorporation. Bone chamber study in rats. Acta Orthop Scand 65:27-31.

23.

Yamada K. , Tabata Y. , Yamamoto K. , Miyamoto S. , Nagata I. , Kikuchi H. , et al. (1997). Potential efficacy of basic fibroblast growth factor incorporated in biodegradable hydrogels for skull bone regeneration . J Neurosurg 86:871-875.